c-met kinase inhibitors (Cephalon)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug Namec-met kinase inhibitors (Cephalon)

Drug Alias NameCEP-5CEP-17940CEP-A

ClassificationSmall molecules

Mechanisms of ActionHepatocyte growth factor receptor inhibitorsAngiogenesis inhibitorsAnticancer protein kinase inhibitors

TargetsHepatocyte growth factor receptor

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCephalon Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCephalon Inc

Active IndicationsN/A

Inactive IndicationsSolid tumours

ATC CodeN/A